Sort
15,842 grants matching “pancreatic cancer”
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
$430,565Julie R Palmer · Boston University Medical Campus · U01 · FY2018 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$430,481Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
VEGF and PDGF in angiogenesis and tumor progression
$430,440David A Cheresh · University Of California, San Diego · R37 · FY2013 · CA
Immune cell control of ovarian cancer
$430,385Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Role of nonsense mediated RNA decay in pancreatic cancer
$430,352Mark Reid Philips · New York University School Of Medicine · R01 · FY2019 · CA
Regulation Of Immune Responses In Humans and in Experimental Animals
$430,295Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Prevention of Type 1 Diabetes with MMP Inhibitors
$430,224City Of Hope/Beckman Research Institute · R21 · FY2002 · DK
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
$430,212Edgar G. Engleman · Stanford University · P01 · FY2025 · CA
Mechanisms of diabetic amyloid formation via 2D IR spectroscopy
$430,078Martin T Zanni · University Of Wisconsin-Madison · R01 · FY2020 · DK
Chemotherapy plus vaccine for metastatic breast cancer
$429,983Johns Hopkins University · R01 · FY2004 · CA
Measuring and Modulating Oxidative DNA Damage Surveillance Pathways
$429,953Eric T. Kool · Stanford University · R01 · FY2017 · CA
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$429,841Lei Zheng · Johns Hopkins University · R01 · FY2017 · CA
Novel Inhibitors of Akt Signaling in Pancreatic Cancer
$429,731Garth Powis · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
PRSS1 Mutation and Pancreatic Cancer Tumorigenesis
$429,661Baoan Ji · Mayo Clinic Jacksonville · R01 · FY2022 · CA
Project 2: Combined CAR-T cell therapy
$429,640Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes
$429,528Stephen J Pandol · Cedars-Sinai Medical Center · U01 · FY2019 · DK
Drug Mechanism of Action-based targeting of tumor subpopulations
$429,473Andrea Califano · Columbia University Health Sciences · U54 · FY2024 · CA
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
$429,377Robert M Straubinger · State University Of New York At Buffalo · R01 · FY2017 · CA
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
$429,377Robert M Straubinger · State University Of New York At Buffalo · R01 · FY2016 · CA
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
$429,377Robert M Straubinger · State University Of New York At Buffalo · R01 · FY2018 · CA
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
$429,300Suresh T. Chari · Mayo Clinic Rochester · U01 · FY2017 · DK
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
$429,300Suresh T. Chari · Mayo Clinic Rochester · U01 · FY2018 · DK
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
$429,300Suresh T. Chari · Mayo Clinic Rochester · U01 · FY2016 · DK
Molecular Magnetic Resonance Imaging of Inflammation
$429,230Eric Michael Gale · Massachusetts General Hospital · R01 · FY2021 · DK
Molecular Magnetic Resonance Imaging of Inflammation
$429,230Eric Michael Gale · Massachusetts General Hospital · R01 · FY2022 · DK